Molecules at the interface of Cryptococcus and the host that determine disease susceptibility

Fungal Genetics and Biology

Volumn 78, Issue , 2015, Pages 87-92

  Wozniak, Karen L ^a   Olszewski, Michal A ^b,c   Wormley, Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Fungal pathogenesis; Host fungal interactions; Medical mycology

Indexed keywords

ANTIBODY; AUTOANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR; CHITIN; CHITINASE; CHITOSAN; CHROMOSOME PROTEIN; CYTOKINE; CYTOKINE RECEPTOR; FUNGAL POLYSACCHARIDE; GALACTOXYLOMANNAN; GLUCURONOXYLOMANNAN; LACCASE; PHOSPHOLIPASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; SPHINGOLIPID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; COMPLEX FORMATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; EXOSOME; FUNGAL CELL WALL; FUNGAL VIRULENCE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; INFECTION RESISTANCE; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; DISEASE PREDISPOSITION; IMMUNOLOGY; PATHOGENICITY;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

CRYPTOCOCCUS NEOFORMANS; DISEASE SUSCEPTIBILITY; HOST-PATHOGEN INTERACTIONS;

EID: 84937848846     PISSN: 10871845     EISSN: 10960937     Source Type: Journal    
DOI: 10.1016/j.fgb.2014.10.013     Document Type: Article

References (59)

1. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin. Microbiol. Infect. 2010, 16:1335-1342.
2. Antachopoulos C., Walsh T., Roilides E. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr. 2007, 166:1099-1117.
3. Arora S., Olszewski M.A., Tsang T.M., McDonald R.A., Toews G.B., Huffnagle G.B. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect. Immun. 2011, 79:1915-1926.
4. Baker L.G., Specht C.A., Donlin M.J., Lodge J.K. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 2007, 6:855-867.
5. Baker L.G., Specht C.A., Lodge J.K. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot. Cell 2011, 10:1264-1268.
6. Bueter C.L., Lee C.K., Rathinam V.A., Healy G.J., Taron C.H., Specht C.A., Levitz S.M. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J. Biol. Chem. 2011, 286:35447-35455.
7. Bueter C.L., Lee C.K., Wang J.P., Ostroff G.R., Specht C.A., Levitz S.M. Spectrum and mechanisms of inflammasome activation by chitosan. J. Immunol. 2014, 192:5943-5951.
8. Chayakulkeeree M., Sorrell T.C., Siafakas A.R., Wilson C.F., Pantarat N., Gerik K.J., Boadle R., Djordjevic J.T. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol. Microbiol. 2008, 69:809-826.
9. Chrisman C.J., Alvarez M., Casadevall A. Phagocytosis of Cryptococcus neoformans by, and Nonlytic Exocytosis from, Acanthamoeba castellanii. Appl. Environ. Microbiol. 2010, 76:6056-6062.
10. Dan J.M., Kelly R.M., Lee C.K., Levitz S.M. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect. Immun. 2008, 76:2362-2367.
11. Davis M.J., Tsang T.M., Qiu Y., Dayrit J.K., Freij J.B., Huffnagle G.B., Olszewski M.A. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 2013, 4. e00264-13.
12. Djordjevic J. Role of phospholipases in fungal fitness, pathogenicity and drug development-lessons from Cryptococcus neoformans. Front. Microbiol. 2010, 1.
13. Flaczyk A., Duerr C.U., Shourian M., Lafferty E.I., Fritz J.R.H., Qureshi S.T. IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans. J. Immunol. 2013, 191:2503-2513.
14. Geijtenbeek T.B.H., van Vliet S.J., Engering A., 't Hart B.A., van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 2004, 22:33-54.
15. Hardison S.E., Herrera G., Young M.L., Hole C.R., Wozniak K.L., Wormley F.L. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J. Immunol. 2012, 189:4060-4068.
16. He X., Lyons D.M., Toffaletti D.L., Wang F., Qiu Y., Davis M.J., Meister D.L., Dayrit J.K., Lee A., Osterholzer J.J., et al. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am. J. Pathol. 2012, 181:1356-1366.
17. Huang S.-H., Wu C.-H., Chang Y.C., Kwon-Chung K.J., Brown R.J., Jong A. Cryptococcus neoformans-derived microvesicles enhance the pathogenesis of fungal brain infection. PLoS ONE 2012, 7:e48570.
18. Jarvis J.N., Harrison T.S. Pulmonary cryptococcosis. Semin. Respir. Crit. Care Med. 2008, 29:141-150.
19. Jarvis J.N., Meintjes G., Rebe K., Williams G.N., Bicanic T., Williams A., Schutz C., Bekker L.G., Wood R., Harrison T.S. Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. Aids 2012, 26:1105-1113.
20. Kronstad J.W., Attarian R., Cadieux B., Choi J., D'Souza C.A., Griffiths E.J., Geddes J.M., Hu G., Jung W.H., Kretschmer M., et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 2011, 9:193-203.
21. Lev S., Desmarini D., Li C., Chayakulkeeree M., Traven A., Sorrell T.C., Djordjevic J.T. Phospholipase C of Cryptococcus neoformans regulates homeostasis and virulence by providing inositol trisphosphate as a substrate for Arg1 kinase. Infect. Immun. 2013, 81:1245-1255.
22. Levitz S.M. Receptor-mediated recognition of Cryptococcus neoformans. Nippon Ishinkin Gakkai Zasshi 2002, 43:133-136.
23. Mansour M.K., Latz E., Levitz S.M. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 2006, 176:3053-3061.
24. McQuiston T., Luberto C., Del Poeta M. Role of host sphingosine kinase 1 in the lung response against Cryptococcosis. Infect. Immun. 2010, 78:2342-2352.
25. McQuiston T., Luberto C., Del Poeta M. Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. Microbiology 2011, 157:1416-1427.
26. Mitchell T.G., Perfect J.R. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 1995, 8:515-548.
27. Monari C., Retini C., Casadevall A., Netski D., Bistoni F., Kozel T.R., Vecchiarelli A. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur. J. Immunol. 2003, 33:1041-1051.
28. Noverr M.C., Williamson P.R., Fajardo R.S., Huffnagle G.B. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 2004, 72:1693-1699.
29. Pappas P.G., Bustamante B., Ticona E., Hamill R.J., Johnson P.C., Reboli A., Aberg J., Hasbun R., Hsu H.H. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J. Infect. Dis. 2004, 189:2185-2191.
30. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids 2009, 23:525-530.
31. Pericolini E., Alunno A., Gabrielli E., Bartoloni E., Cenci E., Chow S.K., Bistoni G., Casadevall A., Gerli R., Vecchiarelli A. The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients. PLoS ONE 2013, 8:e53336.
32. Piehler D., Stenzel W., Grahnert A., Held J., Richter L., Kohler G., Richter T., Eschke M., Alber G., Muller U. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary Cryptococcosis. Am. J. Pathol. 2011, 733-744.
33. Qiu Y., Davis M.J., Dayrit J.K., Hadd Z., Meister D.L., Osterholzer J.J., Williamson P.R., Olszewski M.A. Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination of virulent Cryptococcus neoformans in mice. PLoS ONE 2012, 7:e47853.
34. Rodrigues M.L., Nakayasu E.S., Oliveira D.L., Nimrichter L., Nosanchuk J.D., Almeida I.C., Casadevall A. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 2008, 7:58-67.
35. Rodrigues M.L., Nakayasu E.S., Almeida I.C., Nimrichter L. The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles. J. Proteomics 2014, 97:177-186.
36. Rohatgi S., Gohil S., Kuniholm M.H., Schultz H., Dufaud C., Armour K.L., Badri S., Mailliard R.B., Pirofski L.A. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease. MBio 2013, 4. e00573-13.
37. Romani L., Bistoni F., Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 2002, 10:508-514.
38. Sabiiti W., Robertson E., Beale M.A., Johnston S.A., Brouwer A.E., Loyse A., Jarvis J.N., Gilbert A.S., Fisher M.C., Harrison T.S., et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J. Clin. Investig. 2014, 124:2000-2008.
39. Saijo T., Chen J., Chen S.C., Rosen L.B., Yi J., Sorrell T.C., Bennett J.E., Holland S.M., Browne S.K., Kwon-Chung K.J. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. MBio 2014, 5:e00912-e00914.
40. Singh A., Wang H., Silva L.C., Na C., Prieto M., Futerman A.H., Luberto C., Del Poeta M. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans. Cell. Microbiol. 2012, 14:500-516.
41. Stenzel W., Muller U., Kohler G., Heppner F.L., Blessing M., McKenzie A.N., Brombacher F., Alber G. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am. J. Pathol. 2009, 174:486-496.
42. Subramaniam K., Metzger B., Hanau L.H., Guh A., Rucker L., Badri S., Pirofski L.A. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J. Infect. Dis. 2009, 200:244-251.
43. Subramaniam K.S., Datta K., Marks M.S., Pirofski L.A. Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans. Infect. Immun. 2010, 78:441-452.
44. Subramaniam K.S., Datta K., Quintero E., Manix C., Marks M.S., Pirofski L.A. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 2010, 184:5755-5767.
45. Vecchiarelli A., Pericolini E., Gabrielli E., Kenno S., Perito S., Cenci E., Monari C. Elucidating the immunological function of the Cryptococcus neoformans capsule. Future Microbiol. 2013, 8:1107-1116.
46. Vecchiarelli A., Pericolini E., Gabrielli E., Chow S.-K., Bistoni F., Cenci E., Casadevall A. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Immunotherapy 2011, 3:997-1005.
47. Vibhagool A., Sungkanuparph S., Mootsikapun P., Chetchotisakd P., Tansuphaswaswadikul S., Bowonwatanuwong C., Ingsathit A. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin. Infect. Dis. 2003, 36:1329-1331.
48. Vu K., Tham R., Uhrig J.P., Thompson G.R., Na Pombejra S., Jamklang M., Bautos J.M., Gelli A. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. MBio 2014, 5:e01101-e01114.
49. Pulmonary Innate and Adaptive Defenses against Cryptococcus 2011, ASM Press, Washington, DC. K.L. Williams, F.L. Wormley, S. Geunes-Boyer, J.R. Wright, G.B. Huffnagle (Eds.).
50. Wormley F.L., Perfect J.R., Steele C., Cox G.M. Protection against cryptococcosis using a murine interferon-gamma producing Cryptococcus neoformans strain. Infect. Immun. 2007, 75:1453-1462.
51. T-Cell and DC Responses to Cryptococcus 2011, ASM Press, Washington, DC. K.L. Wozniak, S.M. Levitz (Eds.).
52. Wozniak K.L., Ravi S., Macias S., Young M.L., Olszewski M.A., Steele C., Wormley F.L. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE 2009, 4:e6854.
53. Wozniak K.L., Hardison S.E., Kolls J.K., Wormley F.L. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS ONE 2011, 6:e17204.
54. Wozniak K.L., Hole C.R., Yano J., Fidel P.L., Wormley F.L. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology 2014, 160:1440-1452.
55. Xing J., Wu F., Wang S., Krensky A.M., Mody C.H., Zheng C. Granulysin production and anticryptococcal activity is dependent upon a far upstream enhancer that binds STAT5 in human peripheral blood CD4+ T cells. J. Immunol. 2010, 185:5074-5081.
56. Yauch L.E., Mansour M.K., Shoham S., Rottman J.B., Levitz S.M. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 2004, 72:5373-5382.
57. Yauch L.E., Lam J.S., Levitz S.M. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2006, 2:e120.
58. Zheng C.F., Jones G.J., Shi M., Wiseman J.C., Marr K.J., Berenger B.M., Huston S.M., Gill M.J., Krensky A.M., Kubes P., Mody C.H. Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients. J. Immunol. 2008, 180:7221-7229.
59. Zhu X., Williamson P.R. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res. 2004, 5:1-10.